|
Efficacy and safety of two atypical antipsychotics vs. placebo in patients with an acute exacerbation of either schizophrenia or schizoaffective disorder Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or professional assistance by using a genuine doctor. We aren't mDs. Always consult your physician about Efficacy and safety of two atypical antipsychotics vs. placebo in patients with an acute exacerbation of either schizophrenia or schizoaffective disorder conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Efficacy and safety of two atypical antipsychotics vs. placebo in patients with an acute exacerbation of either schizophrenia or schizoaffective disorder Clinical research trials and Efficacy and safety of two atypical antipsychotics vs. placebo in patients with an acute exacerbation of either schizophrenia or schizoaffective disorder health trials occur in a lot of of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the potency of new does drugs. The role of the studies / undertakings is to figure out specific human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Efficacy and safety of two atypical antipsychotics vs. placebo in patients with an acute exacerbation of either schizophrenia or schizoaffective disorder. Efficacy and safety of two atypical antipsychotics vs. placebo in patients with an acute exacerbation of either schizophrenia or schizoaffective disorder Clinical Trials and other clinical trials permit volunteers to get medical treatment choices before they are available to the general public. Many times the test subjects get professional assistance for free of charge, and occasionally they are compensated for their time. Sometimes there is a cost for a Efficacy and safety of two atypical antipsychotics vs. placebo in patients with an acute exacerbation of either schizophrenia or schizoaffective disorder clinical trial. Human subjects often get the best healthcare possible for their Efficacy and safety of two atypical antipsychotics vs. placebo in patients with an acute exacerbation of either schizophrenia or schizoaffective disorder condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, medical hazards (perhaps life-threatening), and/or the treatment being ineffectual. Trials are federally governed with exacting guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "E" Clinical Trials Conditions > Efficacy and safety of two atypical antipsychotics vs. placebo in patients with an acute exacerbation of either schizophrenia or schizoaffective disorder Efficacy and safety of two atypical antipsychotics vs. placebo in patients with an acute exacerbation of either schizophrenia or schizoaffective disorder
Efficacy and safety of two atypical antipsychotics vs. placebo in patients with an acute exacerbation of either schizophrenia or schizoaffective disorder
For Condition: Schizophrenia,Schizoaffective Disorder
Status: Recruiting
Sponsor(s): Janssen Pharmaceutica ,
Synopsis: A study to evaluate the efficacy and safety of two atypical antipsychotics vs. placebo in patients with an acute exacerbation of either schizophrenia or schizoaffective disorder
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/65 Years
Genders: Both
Protocol Entry Criteria: Current diagnosis of an acute exacerbation of either schizophrenia or schizoaffective disorder
Total Enrollment: 225
Location and Contact Information:
Institute for Neuropsychiatry *Recruiting*
Lake Charles, Louisiana, 70601
United States
Recruiting Barbara Linn 337-494-3266
Neurobehavioral Research, Inc. *Recruiting*
Lawrence, New York, 11559
United States
Recruiting Barbara Linn 516-295-7231
Behavioral and Medical Research *Recruiting*
San Diego, California, 92123
United States
Recruiting Thomas Rosser 858-571-1188
International Clinical Research Associates, LLCc *Recruiting*
Richmond, Virginia, 23294
United States
Recruiting Barbara Linn 804-270-6811
University of MIssissippi Medical Center *Recruiting*
Jackson, Mississippi, 39216
United States
Recruiting Jennifer Frantz 601-984-5660
Sharp Mesa Vista Hospital *Recruiting*
San Diego, California, 92123
United States
Recruiting Thomas Rosser 858-694-8355
Atlanta Center for Medical Research *Recruiting*
Atlanta, Georgia, 30308
United States
Recruiting Barbara Linn 404-881-5800
Clinical Research Inc. *Recruiting*
St. Louis, Missouri, 63118
United States
Recruiting Barbara Linn 314-771-6387
Synergy Clinical Research *Recruiting*
Chula Vista, California, 91910
United States
Recruiting Thomas Rosser 619-426-7272
University Hills Clinical Research *Recruiting*
Irving, Texas, 75062
United States
Recruiting Barbara Linn 972-717-6262
Linden Research Consultants, LLC *Recruiting*
Oklahoma City, Oklahoma, 73116
United States
Recruiting Barbara Linn 405-858-7773
Community Clinical Research, Inc *Recruiting*
Austin, Texas, 78756
United States
Recruiting Barbara Lynn 512-336-6407
University of California-Irvine *Recruiting*
Orange, California, 92868
United States
Recruiting Thomas Rosser 714-456-6315
Additional Information:
Study ID Numbers: RIS-SCP-402;
Study Start Date: June 2003
Record last reviewed: August 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00061802
Other Schizoaffective Disorder Studies:
1. Treatment of Schizophrenia Through Internet-Based Psychoeducation
2. Effects of Modafinil on Brain Function in Patients with Schizophrenia
3. Cognitive - Behavioral Therapy
4. Efficacy and safety of two atypical antipsychotics vs. placebo in patients with an acute exacerbation of either schizophrenia or schizoaffective disorder
5. To Determine If Olanzapine Is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia
Related Studies:
Other Schizoaffective Disorder Clinical Trials
Other Louisiana Clinical Trials
Other Lake Charles Clinical Trials
Efficacy and safety of two atypical antipsychotics vs. placebo in patients with an acute exacerbation of either schizophrenia or schizoaffective disorder
|
|
|
|
|
|
|
|